Article Text

Download PDFPDF
Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies

Footnotes

  • Collaborators Maria Nicoletta Ballarin (previously: Mesothelioma Register of the Veneto Region, Local Health Unit, Padua, Italy), Lucia Bisceglia (Regional Health Agency of Puglia, Bari, Italy), Carol Brentisci (Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, Turin, Italy), Barbara Cortini (Occupational and Environmental Epidemiology Unit - Istituto per lo Studio, la Prevenzione e la Rete oncologica (ISPRO), Florence, Italy), Stefano Mattioli (Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy), Manuela Gangemi (Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, Turin, Italy), Francesco Gioffrè (previously: Mesothelioma Register of the Veneto Region, Local Health Unit, Padua, Italy), Patrizia Legittimo (formerly at Unit of Occupational Medicine, S Orsola-Malpighi University Hospital, Bologna, Italy), Lucia Mangone (Epidemiology Unit, AUSL Reggio Emilia and IRCCS, Reggio Emilia, Italy), Francesco Marinelli (Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy), Pasqualina Marinilli (Department of Public Health, Prevention and Security Area Work Environments, Local Health Authority, Bologna, Italy), Anna Maria Nannavecchia (Regional Health Agency of Puglia, Bari, Italy), Chiara Panato (previously: Mesothelioma Register of the Veneto Region, Local Health Unit, Padua, Italy), Francesca Roncaglia (Epidemiology Unit, AUSL Reggio Emilia and IRCCS, Reggio Emilia, Italy), Cinzia Storchi (Occupational Hygienist; formerly: Regional Agency for Protection, Environment and Energy Emilia-Romagna, Provincial Office of Reggio Emilia, Italy), Antonella Stura (Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, Turin, Italy), Massimo Vicentini (Occupational Hygienist; formerly: Regional Agency for Protection, Environment and Energy Emilia-Romagna, Provincial Office of Reggio Emilia, Italy), Simona Verdi (Istituto per lo Studio, la Prevenzione e la Rete oncologica (ISPRO), Florence, Italy).

  • Contributors FB-A: study design, planning and overview of data analysis, and drafting and critical revision of the article. DF: design of the study, data management, design and conduct of data analysis, and critical revision of the article. AA, MM, PP, AP, FC, SC, AB, LA, ER, FL, OS, CS, SM, EO, LM, GG, VB, VP, EM, EC: design of the study, conduct of the study and critical revision of the article. SS: exposure assessment and critical revision of the article. PG: design of the study and of data analysis and critical revision of the article. ST: data management and critical revision of the article. AR, TC: data management, data analysis and critical revision of the article. AM: design of the study, incidence data collection coordination and critical revision of the article. DM: design of the study, evaluation of exposure information and critical revision of the article. RP: design of the study, overview of mortality data analyses and critical revision of the article. CM: PI of the study, overview of the study and critical revision of the article.

  • Funding The project was partially funded by the Italian National Institute of Health - Istituto Superiore di Sanità (ISS). Asbestos Project - Ricerca corrente 2012: Progetto Amianto. The 'Casaralta' cohort study was partially funded by the Regional Government of Emilia Romagna (Resolution No 6 of the Regional Council of 18/12/2006).

  • Competing interests SM served as expert witness for the judge, the public prosecutor and the defendant’s attorneys in court trials regarding asbestos-related diseases. CM and SS served as expert witnesses for the judge and the public prosecutor in court trials regarding asbestos-related diseases. AA, FB-A, PL, EM, LMi, DM and EO served as expert witnesses for the public prosecutor in court trials regarding asbestos-related diseases. LMa conducted negotiations and stipulated contracts representing the Italian Association of Cancer Registries (AIRTUM) for the preparation and publication of specific reports on the epidemiology of tumour pathologies with MSD, Lilly and Sanofi. All other authors declare they have no actual or potential competing financial interests.

  • Patient consent for publication Not required.

  • Ethics approval The study was approved by the University of Eastern Piedmont Ethical Review Board (Authorisation CE112/13, 12 July 2013) and to the corresponding boards of participating institutions.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement No additional data are available.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Collaborators Maria Nicoletta Ballarin (previously: Mesothelioma Register of the Veneto Region, Local Health Unit, Padua, Italy), Lucia Bisceglia (Regional Health Agency of Puglia, Bari, Italy), Carol Brentisci (Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, Turin, Italy), Barbara Cortini (Occupational and Environmental Epidemiology Unit - Istituto per lo Studio, la Prevenzione e la Rete oncologica (ISPRO), Florence, Italy), Stefano Mattioli (Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy), Manuela Gangemi (Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, Turin, Italy), Francesco Gioffrè (previously: Mesothelioma Register of the Veneto Region, Local Health Unit, Padua, Italy), Patrizia Legittimo (formerly at Unit of Occupational Medicine, S Orsola-Malpighi University Hospital, Bologna, Italy), Lucia Mangone (Epidemiology Unit, AUSL Reggio Emilia and IRCCS, Reggio Emilia, Italy), Francesco Marinelli (Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy), Pasqualina Marinilli (Department of Public Health, Prevention and Security Area Work Environments, Local Health Authority, Bologna, Italy), Anna Maria Nannavecchia (Regional Health Agency of Puglia, Bari, Italy), Chiara Panato (previously: Mesothelioma Register of the Veneto Region, Local Health Unit, Padua, Italy), Francesca Roncaglia (Epidemiology Unit, AUSL Reggio Emilia and IRCCS, Reggio Emilia, Italy), Cinzia Storchi (Occupational Hygienist; formerly: Regional Agency for Protection, Environment and Energy Emilia-Romagna, Provincial Office of Reggio Emilia, Italy), Antonella Stura (Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, Turin, Italy), Massimo Vicentini (Occupational Hygienist; formerly: Regional Agency for Protection, Environment and Energy Emilia-Romagna, Provincial Office of Reggio Emilia, Italy), Simona Verdi (Istituto per lo Studio, la Prevenzione e la Rete oncologica (ISPRO), Florence, Italy).

  • Contributors FB-A: study design, planning and overview of data analysis, and drafting and critical revision of the article. DF: design of the study, data management, design and conduct of data analysis, and critical revision of the article. AA, MM, PP, AP, FC, SC, AB, LA, ER, FL, OS, CS, SM, EO, LM, GG, VB, VP, EM, EC: design of the study, conduct of the study and critical revision of the article. SS: exposure assessment and critical revision of the article. PG: design of the study and of data analysis and critical revision of the article. ST: data management and critical revision of the article. AR, TC: data management, data analysis and critical revision of the article. AM: design of the study, incidence data collection coordination and critical revision of the article. DM: design of the study, evaluation of exposure information and critical revision of the article. RP: design of the study, overview of mortality data analyses and critical revision of the article. CM: PI of the study, overview of the study and critical revision of the article.

  • Funding The project was partially funded by the Italian National Institute of Health - Istituto Superiore di Sanità (ISS). Asbestos Project - Ricerca corrente 2012: Progetto Amianto. The 'Casaralta' cohort study was partially funded by the Regional Government of Emilia Romagna (Resolution No 6 of the Regional Council of 18/12/2006).

  • Competing interests SM served as expert witness for the judge, the public prosecutor and the defendant’s attorneys in court trials regarding asbestos-related diseases. CM and SS served as expert witnesses for the judge and the public prosecutor in court trials regarding asbestos-related diseases. AA, FB-A, PL, EM, LMi, DM and EO served as expert witnesses for the public prosecutor in court trials regarding asbestos-related diseases. LMa conducted negotiations and stipulated contracts representing the Italian Association of Cancer Registries (AIRTUM) for the preparation and publication of specific reports on the epidemiology of tumour pathologies with MSD, Lilly and Sanofi. All other authors declare they have no actual or potential competing financial interests.

  • Patient consent for publication Not required.

  • Ethics approval The study was approved by the University of Eastern Piedmont Ethical Review Board (Authorisation CE112/13, 12 July 2013) and to the corresponding boards of participating institutions.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement No additional data are available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.